Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIMM23B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
HERC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
URI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MATR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARNP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFI16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD58 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERICH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DRAM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL6R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR160 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCFC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YES1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDCA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on